Introduction: There is limited information on the incidence of diabetes despite INDIA being the Global capital for Diabetes.
Though much of data is available in patients already diagnosed with diabetes but data regarding the new onset diabetes in
the subset of Acute coronary syndrome (ACS) is very limited.
Materials and methods: This was a Cohort study in which 200 consecutive ACS patients were included. Lab data about their
FBS; PPBS; Lipid profile & Hba1c, BMI, BP and their clinical status was collected at the time of admission, after discharge
at 2 weeks, 6 weeks & 3,6 & 12 months post ACS.
Results: In study 85% were males. Mean age was 56 years. Prevalence of various atherosclerotic risk factors in study
population matched the regional prevalence of them.
20% (n=40) developed New onset diabetes (NOD), 2.5% (n=5) developed Impaired fasting Glucose, 6% (n=12) developed
Impaired glucose tolerance in and 1.5% (n=3) developed both Impaired fasting glucose and Impaired Glucose tolerance
over a follow up period of 1 year. MACE rates & Revascularisation rates were significantly higher in NOD population.
NOD patients had significantly higher BMI, waist circumference, BP, TG, LDL and Low HDL. NOD patients were on Higher
dosage of statins, diuretics and Beta blockers.
Conclusion: The study highlights two important things, first incidence of new onset diabetes in acute coronary syndrome
patients is High, second new onset diabetes has a significant impact on the clinical outcome of ACS patients
Impact of Single Nucleotide Polymorphisms and of Clinical Risk Factors on New‐Onset Diabetes Mellitus in HIV‐Infected Individuals
